TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Amplia Therapeutics ( (AU:ATX) ) has shared an announcement.
Amplia Therapeutics Limited has announced the cessation of 2,355,000 securities due to the expiry of options or other convertible securities without exercise or conversion. This announcement may impact the company’s capital structure but does not indicate any immediate operational changes or strategic shifts.
The most recent analyst rating on (AU:ATX) stock is a Buy with a A$0.42 price target. To see the full list of analyst forecasts on Amplia Therapeutics stock, see the AU:ATX Stock Forecast page.
More about Amplia Therapeutics
YTD Price Performance: 74.16%
Average Trading Volume: 7,216,964
Technical Sentiment Signal: Hold
Current Market Cap: A$79.53M
See more insights into ATX stock on TipRanks’ Stock Analysis page.